He Huang
2 clinical trials · 2 recruiting · OTHER
Trials by He Huang
RECRUITINGEarly Phase 1NCT04227015
A Study of CTA101 UCAR-T Cell Injection in Patients With Relapsed or Refractory CD19+ B-line Hematological Malignancy
A study of CTA101 UCAR-T cell injection in patients with relapsed or refractory CD19+ B-line hematological malignancy
Sponsor: He HuangEnrolling: 721 location
Acute Lymphoblastic LeukemiaNon-hodgkin Lymphoma
RECRUITINGNCT06162338
A Study of the Safety and Preliminary Efficacy of LY-M001 Injection in the Treatment of Adult Patients With Gaucher...
This is a prospective single-center, open, single-arm, single-dose intravenous infusion study to evaluate the safety and initial efficacy, pharmacodynamic characteristics,...
Sponsor: He HuangEnrolling: 31 location
Gaucher Disease Type I